What doctors should consider before prescribing e‐liquids for e‐cigarettes

In reply: We thank Mendelsohn and Beaumont1 for their commitment to tobacco harm reduction and we agree that a personalised approach is likely to be most beneficial. However, nicotine prescriptions have been thrust upon Australian medical professionals with effectively no guidance, especially as to how a personalised approach should and could be implemented. Our approach takes into account current evidence to provide a foundation for prescribing e‐cigarettes until the necessary data become available.2 Our intent was to provide information for all clinicians, including general practitioners and pharmacists, especially for those with minimal experience implementing smoking cessation who may be approached to prescribe e‐cigarettes.